Welcome to our dedicated page for Mediwound SEC filings (Ticker: MDWD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading MediWound鈥檚 SEC disclosures can feel like sorting through lab notes鈥攈undreds of pages packed with clinical-trial data, BARDA reimbursements, and cautionary language about cash runway. If you have ever searched 鈥渨here can I find MediWound鈥檚 quarterly earnings report 10-Q filing鈥� or needed 鈥淢ediWound insider trading Form 4 transactions鈥� before the market reacts, you know the challenge.
Stock Titan turns that complexity into clarity. Our AI studies every 10-K, 10-Q, 8-K, and proxy statement in real time, then highlights what investors care about:
- Pipeline milestones for NexoBrid, EscharEx, and MW005
- Breakdowns of R&D expense versus available cash
- Partnership revenue and government grants
- Executive stock transactions with instant Form 4 alerts
From 鈥渦nderstanding MediWound SEC documents with AI鈥� to monitoring 鈥淢ediWound executive stock transactions Form 4,鈥� professionals rely on Stock Titan鈥檚 complete coverage. AG真人官方-time feeds, searchable exhibits, and concise AI-powered briefs mean no more digging through dense PDFs. Save hours, capture nuance, and make informed calls on MediWound鈥檚 future鈥攚hether you鈥檙e tracking BARDA contract amendments or comparing quarter-over-quarter burn rates. The filings are complex; we make them clear.
Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon report beneficial ownership of 570,326 MediWound common shares, representing 5.2% of outstanding shares based on 10,793,057 shares. The position comprises 407,061 issued common shares and 163,265 shares issuable upon exercise of warrants. Each reporting person discloses shared voting and dispositive power over 407,061 shares and no sole voting or dispositive power. The reported warrants contain a blocker provision preventing exercise to the extent such exercise would raise beneficial ownership above 9.99%. The advisor and Mr. Salamon disclaim beneficial ownership of shares held by the fund.
FAQ
What is the current stock price of Mediwound (MDWD)?
What is the market cap of Mediwound (MDWD)?
